Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania

19Citations
Citations of this article
223Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Within the context of combined interventions, malaria vaccine may provide additional value in malaria prevention. Stakeholders' perspectives are thus critical for informed recommendation of the vaccine in Tanzania. This paper presents the views of stakeholders with regards to malaria vaccine in 12 Tanzanian districts. Methods: Quantitative and qualitative methods were employed. A structured questionnaire was administered to 2123 mothers of under five children. Forty-six in-depth interviews and 12 focus group discussions were conducted with teachers, religious leaders, community health workers, health care professionals, and scientists. Quantitative data analysis involved frequency distributions and cross tabulations using Chi square test to determine the association between malaria vaccine acceptability and independent variables. Qualitative data were analysed thematically. Results: Overall, 84.2 % of the mothers had perfect acceptance of malaria vaccine. Acceptance varied significantly according to religion, occupation, tribe and region (p < 0.001). Ninety two percent reported that they will accept the malaria vaccine despite the need to continue using insecticide-treated nets (ITNs), while 88.4 % reported that they will accept malaria vaccine even if their children get malaria less often than non-vaccinated children. Qualitative results revealed that the positive opinions towards malaria vaccine were due to a need for additional malaria prevention strategies and expectations that the vaccine will reduce visits to the health facility, deaths, malaria episodes and treatment-related expenses. Vaccine related questions included its side effects, efficacy, protective duration, composition, interaction with other medications, provision schedule, availability to the pregnant women, mode of administration (oral or injection?) and whether a child born of HIV virus or with a chronic illness will be eligible for the vaccine? Conclusion: Stakeholders had high acceptance and positive opinions towards the combined use of the anticipated malaria vaccine and ITNs, and that their acceptance remains high even when the vaccine may not provide full protection, this is a crucial finding for malaria vaccine policy decisions in Tanzania. An inclusive communication strategy should be designed to address the stakeholders' questions through a process that should engage and be implemented by communities and health care professionals. Social cultural aspects associated with vaccine acceptance should be integrated in the communication strategy.

Figures

  • Table 1 Study regions and the selected districts
  • Table 2 Characteristics of the respondents in 2013 household survey (n = 2123)
  • Fig. 1 Percent distribution of respondents that believe that there are benefits related to under-five child vaccination (n = 2123)
  • Table 4 Perception towards  vaccine: percent distribution of  respondents that  AGREE with  the listed statements by region (n = 2123)
  • Table 5 Degree of malaria vaccine acceptability by various characteristics (n = 2123)
  • Table 6 continued
  • Table 6 Percent distribution of  respondents ready to  get their children vaccinated with malaria vaccine despite the fact that  even though  a child is vaccinated, s/he will still have to  use ITNs and  seek treatment if  s/he has fever; by various characteristics (n = 2123)
  • Table 7 continued

References Powered by Scopus

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

732Citations
N/AReaders
Get full text

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

613Citations
N/AReaders
Get full text

Is verbatim transcription of interview data always necessary?

476Citations
N/AReaders
Get full text

Cited by Powered by Scopus

RTS,S malaria vaccine pilot studies: Addressing the human realities in large-scale clinical trials

34Citations
N/AReaders
Get full text

Current challenges and proposed solutions to the effective implementation of the RTS, S/ AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review

32Citations
N/AReaders
Get full text

Transmission-Blocking Vaccines for Malaria: Time to Talk about Vaccine Introduction

31Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mtenga, S., Kimweri, A., Romore, I., Ali, A., Exavery, A., Sicuri, E., … Kafuruki, S. (2016). Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania. Malaria Journal, 15(1). https://doi.org/10.1186/s12936-016-1209-6

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 79

66%

Researcher 23

19%

Lecturer / Post doc 12

10%

Professor / Associate Prof. 6

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 42

42%

Nursing and Health Professions 27

27%

Social Sciences 19

19%

Agricultural and Biological Sciences 11

11%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 2147

Save time finding and organizing research with Mendeley

Sign up for free
0